Atommerce

About Atommerce

Atommerce operates as a comprehensive mental healthcare provider, primarily targeting the South Korean market with emerging activities in Japan. The company was established in 2015 by CEO Kyu-Tae Kim. His personal experience with overcoming depression through therapy while studying in the United States motivated him to create a more accessible mental health solution in South Korea, where social stigma often hinders individuals from seeking help. He identified a gap in the market where many people resorted to unscientific methods for psychological issues and aimed to provide a scientific, technology-driven alternative.

The company's core offering is the 'MiND CAFE' platform, which started as an anonymous online community in 2016 to lower the barrier to discussing mental health. It has since evolved into a multifaceted service. The business model incorporates both business-to-consumer (B2C) and business-to-business/government (B2B/B2G) streams. Revenue is generated from paid services on its platform. For individual users, MiND CAFE offers tele-counseling via chat, phone, and video with vetted professionals, as well as coaching programs for personal development in areas like career and relationships. A significant part of its business is the Employee Assistance Program (EAP), providing mental wellness solutions to corporate and government clients, including Samsung, Naver, Hyundai, and the Seoul Metropolitan Government. This B2B service has shown strong growth with no client attrition reported.

The MiND CAFE service ecosystem is extensive. It began with an anonymous community for peer support and has expanded to include 'MiND CAFE Pro' for professional, one-on-one counseling. Recognizing the limitations of non-face-to-face interaction, Atommerce launched physical 'MiND CAFE Psychology Counseling Centers' starting in 2020. In a strategic move to broaden its service portfolio, the company acquired the meditation and mindfulness app 'Kokkiri' in 2023, integrating over 1,500 pieces of content to enhance its offerings, particularly for EAP clients and users seeking sleep care solutions. The company is also developing AI technology to support its human therapists and exploring digital therapeutics to position itself as a broader biotech firm.